ENvue Medical (FEED) Return on Capital Employed (2015 - 2026)
ENvue Medical's (FEED) quarterly Return on Capital Employed came in at 73.58% in Q1 2026, down 4252.0% year-on-year from 1.77% in Q1 2025, and down 32.11% on a QoQ basis from 55.7% in Q4 2025.
ENvue Medical (FEED) Return on Capital Employed (2015 - 2026) Analysis & Trends
ENvue Medical (FEED) has 12 years of Return on Capital Employed data on file, last reported at 73.58% in Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 4252.0% year-over-year to 73.58% in Q1 2026; TTM through Mar 2026 was 73.58%, a 4252.0% decrease from a year earlier, with the FY2025 full-year figure at 145.64%, up 180.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 73.58%, down from 55.7% in the prior quarter.
- Over the last five years, Return on Capital Employed for FEED reached as high as 19.8% in Q2 2025 and fell as low as 249.88% in Q4 2024.
- Historically, Return on Capital Employed has averaged 107.48% across 5 years, with a median of 89.33% in 2022.
- Across the five-year window, Return on Capital Employed slumped 17458 bps in 2024 and surged 19418 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 155.24% in 2022, then jumped by 51 bps to 75.29% in 2023, then slumped by 232 bps to 249.88% in 2024, then surged by 78 bps to 55.7% in 2025, then slumped by 32 bps to 73.58% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 73.58% in Q1 2026, 55.7% in Q4 2025, and 22.88% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 24.24% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 9.30% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 8.38% |
| 10 | ENvue Medical | 1.18 Mn | -1.09 Mn | -55,000.00 | -73.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.58% |
| Dec 31, 2025 | -55.70% |
| Sep 30, 2025 | -22.88% |
| Jun 30, 2025 | -19.80% |
| Mar 31, 2025 | -31.06% |
| Dec 31, 2024 | -249.88% |
| Sep 30, 2024 | -109.22% |
| Jun 30, 2024 | -76.67% |
| Mar 31, 2024 | -73.22% |
| Dec 31, 2023 | -75.29% |
| Sep 30, 2023 | -138.64% |
| Jun 30, 2023 | -240.70% |
| Mar 31, 2023 | -162.14% |
| Dec 31, 2022 | -155.24% |
| Sep 30, 2022 | -139.73% |
| Jun 30, 2022 | -114.03% |
| Mar 31, 2022 | -89.33% |
| Dec 31, 2021 | -78.48% |
| Sep 30, 2021 | -59.04% |
| Jun 30, 2021 | -63.45% |